Yazmín Karina Márquez Flores

Dr. Yazmín Karina Márquez Flores

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
YFYazmín Karina Márquez Flores
Yazmín Karina Márquez Flores
IVIsabel Villegas
Isabel Villegas
ACAna Cárdeno
Ana Cárdeno
MRMaría Angeles Rosillo
María Angeles Rosillo
CDCatalina Alarcòn de-la-Lastra
Catalina Alarcòn de-la-Lastra

20 November 2011 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
YFYazmín Karina Márquez Flores
Yazmín Karina Márquez Flores
MCMaria-Elena Campos-Aldete
Maria-Elena Campos-Aldete
HSHéctor Salgado-Zamora
Héctor Salgado-Zamora
JCJosé Correa-Basurto
José Correa-Basurto
MMMaria Estela Melendez-Camargo
Maria Estela Melendez-Camargo

8 February 2011 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
YFYazmín Karina Márquez Flores
Yazmín Karina Márquez Flores
MCMaria-Elena Campos-Aldete
Maria-Elena Campos-Aldete
HSHéctor Salgado-Zamora
Héctor Salgado-Zamora
JCJosé Correa-Basurto
José Correa-Basurto
MMMaria Estela Melendez-Camargo
Maria Estela Melendez-Camargo

1 July 2008 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FMFederico Martínez-Ramos
Federico Martínez-Ramos
HSHector Salgado-Zamora
Hector Salgado-Zamora
MCMaria-Elena Campos-Aldete
Maria-Elena Campos-Aldete
MMMaria Estela Melendez-Camargo
Maria Estela Melendez-Camargo
YFYazmín Karina Márquez Flores
Yazmín Karina Márquez Flores
MSManuel Soriano-García
Manuel Soriano-García

16 May 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YFYazmín Karina Márquez Flores
Yazmín Karina Márquez Flores
EMElizdath Martínez-Galero
Elizdath Martínez-Galero
CJCORREA BASURTO JOSE
CORREA BASURTO JOSE
Yudibeth Sixto-LópezYudibeth Sixto-López
Yudibeth Sixto-López
IVIsabel Villegas
Isabel Villegas
CDCatalina Alarcòn de-la-Lastra
Catalina Alarcòn de-la-Lastra
Background: The inflammasome is a cytosolic multiprotein complex associated with multiple autoimmune diseases. Phytochemical compounds in soy (Glycine max) foods, such as isoflavones, have been reported for their anti-inflammatory properties. Aim: the anti-inflammatory activity of DZ (daidzein) and EQ (equol) were investigated in an ex vivo model of LPS-stimulated murine peritoneal macrophages and by molecular docking correlation. Methods: Cells were pre-treated with DZ (25, 50, and 100 µM) or EQ (5, 10, and 25 µM), followed by LPS stimulation. The levels of PGE2, NO, TNF-α, IL-6, and IL-1β were analyzed by ELISA, whereas the expressions of COX-2, iNOS, NLRP3, ASC, caspase 1, and IL-18 were measured by Western blotting. Also, the potential for transcriptional modulation by targeting NF-κB, COX-2, iNOS, NLRP3, ASC, and caspase 1 was investigated by molecular docking. Results: The anti-inflammatory responses observed may be due to the modulation of NF-κB due to the binding of DZ or EQ, which is translated into decreased TNF-α, COX-2, iNOS, NLRP3, and ASC levels. Conclusion: This study establishes that DZ and EQ inhibit LPS-induced inflammatory responses in peritoneal murine macrophages via down-regulation of NO and PGE2 generation, as well as the inhibition of the canonical inflammasome pathway, regulating NLRP3, and consequently decreasing IL-1β and IL-18 activation.

1 December 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
NCNatalia Calva-Candelaria
Natalia Calva-Candelaria
MMMaría Estela Meléndez-Camargo
María Estela Meléndez-Camargo
HMHortensia Montellano-Rosales
Hortensia Montellano-Rosales
AEAlan R. Estrada-Pérez
Alan R. Estrada-Pérez
MRMartha C. Rosales-Hernández
Martha C. Rosales-Hernández
YFYazmín Karina Márquez Flores
Yazmín Karina Márquez Flores
Oenothera rosea L´Hér. ex Ait is a species traditionally used in the treatment of inflammation, headache, stomach pain, infections, among others. The aim of this study was evaluating the acute anti-inflammatory activity of the aqueous extract of O. rosea by 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis. Rats were randomized into six groups: (I) Sham; (II) EtOH; (III) TNBS; and (IV-VI) 250, 500 and 750 mg/Kg, respectively. The colonic injury was induced (groups III-VI) by intrarectal instillation of 0.25 mL of TNBS (10 mg) in 50% ethanol. Groups I and II received an enema (0.25 mL) of physiological saline solution or 50% ethanol, respectively. Treatments were administered by oral gavage 48, 24 and 1 h prior, and 24 h after the induction. The inflammatory response was assessed considering the macroscopic and microscopic damage, the serum nitric oxide (NO), the colonic IL-1β levels, and the myeloperoxidase (MPO) activity. Moreover, we performed an LC-MS-based metabolite profiling, and a docking on the MPO. Doses of 500 and 750 mg/Kg showed a protective effect in the TNBS-induced colonic damage. This activity was related to the downregulation of evaluated parameters. Also, considering previous reports, 29 metabolites of 91 detected were selected for the docking, of which Isolimonic acid (29) and Kaempferol 3-(2'',4''-diacetylrhamnoside) (10) showed the highest affinity to MPO. The aqueous extract of O. rosea protected the TNBS-induced colonic damage in rats, an effect that could be associated with the presence of polyphenolic compounds, alkaloids, and terpenes; as well as their ability to down-regulate MPO activity.